Mariama Akodad, Maximilian Kütting, Stephanie Sellers, Alina Kirsten, Philipp Marx, Isabel Kim, Anson Cheung, Jonathon Leipsic, Lars Søndergaard, Stefan Toggweiler, David A Wood, John G Webb, Janarthanan Sathananthan
PURPOSE: Failure of transcatheter heart valves (THV) may potentially be treated with repeat transcatheter aortic valve implantation (redo TAVI). We assessed hydrodynamic performance, stability and pinwheeling utilizing the ALLEGRA (New Valve Technology, Hechingen, Germany) THV, a CE approved and marketed THV in Europe, inside different THVs. METHODS: Redo TAVI was simulated with the 27 mm ALLEGRA THV at three implantation depths (-4 mm, 0 mm and +4 mm) in seven different 'failed' THVs: 26 mm Evolut Pro, 25 mm Lotus, 25 mm JenaValve, 25 mm Portico, 23 mm Sapien 3, 27 mm ALLEGRA and M ACURATE neo...
May 3, 2022: Cardiovascular Engineering and Technology